167.47
-2.97(-1.74%)
Currency In USD
| Previous Close | 170.44 |
| Open | 171.25 |
| Day High | 173 |
| Day Low | 164.52 |
| 52-Week High | 173 |
| 52-Week Low | 111.09 |
| Volume | 927,679 |
| Average Volume | 520,103 |
| Market Cap | 10.02B |
| PE | -22.51 |
| EPS | -7.44 |
| Moving Average 50 Days | 155.01 |
| Moving Average 200 Days | 138.24 |
| Change | -2.97 |
If you invested $1000 in Ascendis Pharma A/S (ASND) 10 years ago, it would be worth $9,714.04 as of May 02, 2025 at a share price of $167.47. Whereas If you bought $1000 worth of Ascendis Pharma A/S (ASND) shares 5 years ago, it would be worth $1,281.72 as of May 02, 2025 at a share price of $167.47.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025
GlobeNewswire Inc.
Apr 24, 2025 8:01 PM GMT
COPENHAGEN, Denmark, April 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced it will report first quarter 2025 financial results and provide a business update on Thursday, May 1, 2025, after the close of the U.S. finan
Ascendis Submits U.S. NDA for TransCon CNP (Navepegritide) for the Treatment of Children with Achondroplasia
GlobeNewswire Inc.
Mar 31, 2025 8:01 PM GMT
— Data demonstrated multiple clinical benefits beyond linear growth — NDA supported by data from three randomized, double-blind, placebo-controlled clinical trials in children with achondroplasia, with up to three years of open-label extension data
Ascendis Pharma to Participate in the TD Cowen 45th Annual Health Care Conference
GlobeNewswire Inc.
Feb 24, 2025 9:01 PM GMT
COPENHAGEN, Denmark, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4, 2025, at 1